| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 237.33B | 238.93B | 180.84B | 245.72B | 245.43B |
| Gross Profit | 97.89B | 101.74B | 68.00B | 93.97B | 100.36B |
| EBITDA | 58.89B | 64.85B | 42.03B | 67.28B | 80.61B |
| Net Income | 32.77B | 36.00B | 22.37B | 40.30B | 51.34B |
Balance Sheet | |||||
| Total Assets | 352.11B | 341.51B | 375.43B | 373.54B | 356.53B |
| Cash, Cash Equivalents and Short-Term Investments | 47.73B | 44.76B | 92.62B | 106.05B | 108.40B |
| Total Debt | 55.84B | 60.18B | 93.02B | 99.21B | 123.19B |
| Total Liabilities | 139.26B | 145.34B | 188.04B | 212.66B | 237.01B |
| Stockholders Equity | 212.84B | 196.17B | 187.39B | 160.88B | 119.52B |
Cash Flow | |||||
| Free Cash Flow | 34.55B | 12.99B | -8.59B | 23.18B | 70.51B |
| Operating Cash Flow | 46.22B | 38.48B | 2.94B | 29.99B | 73.61B |
| Investing Cash Flow | -15.63B | -27.71B | -11.95B | -7.83B | -3.35B |
| Financing Cash Flow | -44.34B | -58.11B | -6.31B | -25.11B | -3.51B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥3.01T | 25.03 | 53.12% | 1.11% | 32.51% | 57.19% | |
79 Outperform | ¥18.49T | 33.18 | 26.01% | 1.79% | 16.74% | 16.03% | |
78 Outperform | ¥1.80T | 15.60 | 21.73% | 2.29% | 11.29% | 11.38% | |
77 Outperform | ¥16.34T | 45.29 | 47.37% | 0.25% | 63.36% | 149.43% | |
75 Outperform | ¥7.37T | 35.55 | 25.78% | 0.79% | 13.45% | 20.37% | |
62 Neutral | ¥1.40T | 44.15 | ― | 0.73% | 10.98% | 6.51% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |